Alterity Therapeutics (ATHE) Accounts Payables (2009 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Accounts Payables of $1.0 million for Q4 2025, down 21.85% year-over-year from $1.3 million in Q4 2024, and down 36.45% quarter-over-quarter from $1.6 million in Q2 2025.
Alterity Therapeutics (ATHE) Accounts Payables (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Accounts Payables history runs 17 years deep, the most recent figure standing at $1.0 million for Q4 2025.
- In Q4 2025, Accounts Payables fell 21.85% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (down 21.85% YoY), while the FY2025 annual figure was $1.6 million, down 45.83% from the prior year.
- Accounts Payables for Q4 2025 stood at $1.0 million, down from $1.6 million in the prior quarter.
- The five-year high for Accounts Payables was $3.6 million in Q2 2022, with the low at $35177.1 in Q2 2023.
- The 5-year median for Accounts Payables is $1.8 million (2021), against an average of $1.7 million.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables sank 99.03% in 2023, then jumped 3470.23% in 2025.
- Alterity Therapeutics' Accounts Payables stood at $2.3 million in 2021, then grew by 27.9% to $2.9 million in 2022, then dropped by 19.05% to $2.4 million in 2023, then sank by 43.27% to $1.3 million in 2024, then slipped by 21.85% to $1.0 million in 2025.
- Business Quant data shows ATHE's Accounts Payables at $1.0 million in Q4 2025, $1.6 million in Q2 2025, and $1.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 35.57 Mn |
| 10 | Alterity Therapeutics | 48.08 Mn | 15.78 Mn | - | 1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Jun 30, 2024 | 46,199.47 |
| Dec 31, 2023 | 2.36 Mn |
| Jun 30, 2023 | 35,177.08 |
| Dec 31, 2022 | 2.92 Mn |
| Jun 30, 2022 | 3.64 Mn |
| Dec 31, 2021 | 2.28 Mn |
| Jun 30, 2021 | 1.93 Mn |
| Dec 31, 2020 | 1.70 Mn |
| Jun 30, 2020 | 1.36 Mn |
| Dec 31, 2019 | 1.79 Mn |
| Jun 30, 2019 | 1.90 Mn |
| Dec 31, 2018 | 1,916.24 |
| Jun 30, 2018 | 1.56 Mn |
| Dec 31, 2017 | 945,765.93 |
| Jun 30, 2017 | 670.38 |
| Dec 31, 2016 | 1.59 Mn |
| Jun 30, 2016 | 1,305.68 |